Vermillion Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$262K Sell
1,032
-162
-14% -$37.8K 0.06% 141
2026
Q1
$292K Buy
1,194
+163
+16% +$38K 0.11% 81
2025
Q4
$213K Buy
1,031
+98
+11% +$19.4K 0.09% 94
2025
Q3
$173K Buy
933
+13
+1% +$2.23K 0.05% 247
2025
Q2
$141K Buy
920
+14
+2% +$2.15K 0.07% 102
2025
Q1
$150K Sell
906
-13
-1% -$2.03K 0.04% 240
2024
Q4
$133K Buy
+919
New +$142K 0.07% 106

Other funds holding JNJ

Vermillion Wealth Management's JNJ Position: Q2 2026 in Review

Vermillion Wealth Management reduced its Johnson & Johnson (JNJ) stake by 14% in Q2 2026, selling an estimated $37.8K and leaving 1,032 shares worth $262K. The position accounts for 0.06% of the portfolio, ranked #141.

Vermillion Wealth Management first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. The position peaked at $292K in Q1 2026. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Vermillion Wealth Management held 1,032 shares of Johnson & Johnson worth $262K as of Q2 2026.
  • Vermillion Wealth Management sold 162 Johnson & Johnson shares in Q2 2026, an estimated $37.8K.
  • Johnson & Johnson made up 0.06% of Vermillion Wealth Management's portfolio in Q2 2026, its #141 holding.
  • Vermillion Wealth Management first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • Vermillion Wealth Management's Johnson & Johnson position peaked at $292K in Q1 2026.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.